AAI
CNMD icon

Aequim Alternative Investments’s CONMED CNMD Stock Holding History

Aequim Alternative Investments’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,025
Closed -$1.09M – 136
2022
Q2 		$1.09M Buy
+2,025
New +$243K 0.03% 118

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aequim Alternative Investments's CNMD Position: Q3 2022 in Review

Aequim Alternative Investments sold out of CONMED (CNMD) in Q3 2022, closing a stake of 2,025 shares — an estimated $1.09M sold.

Aequim Alternative Investments first reported a position in CNMD in Q2 2022 and held it in 1 quarter. The position peaked at $1.09M in Q2 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Aequim Alternative Investments reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
  • Aequim Alternative Investments sold 2,025 CONMED shares in Q3 2022, an estimated $1.09M.
  • Aequim Alternative Investments first reported a position in CONMED in Q2 2022 and held it in 1 quarter.
  • Aequim Alternative Investments's CONMED position peaked at $1.09M in Q2 2022.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Aequim Alternative Investments's 13F filing for Q3 2022, filed 14 Nov 2022.